A phase I trial assessing the safety, tolerability, pharmacokinetic and pharmacodynamic characteristics of single‐dose Auron Misheil therapy in healthy male subjects

Publisher: John Wiley & Sons Inc

E-ISSN: 1365-2710|269-4727|1|3-11

ISSN: 0269-4727

Source: JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol.269-4727, Iss.1, 2013-02, pp. : 3-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content